COBB STUART (Chief Scientific Officer) sold 18.2% of their position (6.80K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $141.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/17/2026ACC: 0001994301-26-000004
Officer· Chief Scientific Officer
Since Feb 2026
-6.80K
Net shares
Net seller
$141.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
6.80K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−3.99K
Price / share
$20.41
Trade value
$81.46K
% of position
10.7%
3/13/2026
37.29K→33.30K
Common Stock
Direct
Shares
−2.66K
Price / share
$21.34
Trade value
$56.72K
% of position
8.0%
3/13/2026
33.30K→30.64K
Common Stock
Direct
Shares
−148.00
Price / share
$22.08
Trade value
$3.27K
% of position
0.5%
3/13/2026
30.64K→30.50K
Total
Net shares
−6.80K
Net value
-$141.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2026 | S · Sale | −3.99K | $20.41 | $81.46K | 10.7% | 37.29K | 33.30K |
| Common Stock Direct | 3/13/2026 | S · Sale | −2.66K | $21.34 | $56.72K | 8.0% | 33.30K | 30.64K |
| Common Stock Direct | 3/13/2026 | S · Sale | −148.00 | $22.08 | $3.27K | 0.5% | 30.64K | 30.50K |
| Total | −6.80K | -$141.45K | ||||||
Derivative Transactions0
No derivative transactions reported